FDA Webview
X
about-us-banner

Articles

Home /Articles / FDA Federal Register Notices

Guidance on Advisory Panelist Financial Info Availability

03/09/2012

Federal Register Notice: FDA is making available Guidance for the Public, FDA Advisory Committee Members, and FDA Staff: Public Av...

Panel to Discuss Pneumonic Plague

03/07/2012

Panel to Discuss Regeneron’s Gout Treatment

03/07/2012

Federal Register Notice: FDA’s Arthritis Advisory Committee will meet 5/8, from 8:30 a.m. to 5 p.m. at FDA White Oak Campus...

Public Hearing on Modernizing Clinical Trial Regulation

03/07/2012

Federal Register Notice: FDA will hold a public hearing 4/23-24 to obtain input on the agency’s direction in modernizing the...

Advisory Committee Annual Reports Filed

03/05/2012

Federal Register Notice: FDA has filed with the Library of Congress the annual reports of those FDA advisory committees that held ...

Guidance on Limiting Phthalates as Excipients in Pharmaceuticals

03/02/2012

Federal Register Notice: FDA is making available a draft guidance for industry, Limiting the Use of Certain Phthalates as Excipien...

Public Hearing on Biosimilar Guidances

03/02/2012

Federal Register Notice: FDA is sponsoring a public hearing 5/11 to obtain input on recently issued draft guidances on developing ...

FDA Sends Info on Device Labeling Survey to OMB

03/01/2012

FDA Releases Draft BE Recommendations

02/22/2012

Federal Register Notice: FDA is making available additional draft and revised draft product-specific bioequivalence (BE) recommend...

Cincinnati District, Xavier Plan Device Conference

02/22/2012

Federal Register Notice: FDA Cincinnati District will co-sponsor 5/2-4 with Xavier University a public conference entitled "FDA/Xa...